Biomerica, Inc. - Common Stock (BMRA)

After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.

Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.

Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top gainers and losers in today's session.

Every eight shares of Biomerica’s pre-split common stock issued and outstanding will be automatically reclassified as and converted into one new share of Biomerica’s common stock on Monday.

The market is filled with gapping stocks in Wednesday's session. Let's discover which stocks are showing gap-ups and gap-downs.

The latest approval aligns with Biomerica’s strategy to broaden its presence in the Middle East, a region where prostate cancer is increasingly viewed as a pressing health issue.

U.S. stock markets experienced a downturn on Thursday, with the Nasdaq Composite shedding over 170 points and ending the day at 19,338.29.

Biomerica's Fortel PSA test gains UAE approval for prostate cancer detection. Q2 shows 5% sales growth and reduced losses through cost optimization.

It's time to dive into the biggest pre-market stock movers as we check out all of the latest news worth reading about on Tuesday morning!